Two important tests that previously required a visit to a healthcare clinic have now received CE certification to be performed at home using the patient’s own mobile camera and an AI app. FindOut Diagnostic is the company behind the invention and will soon launch the blood tests CRP and HbA1c, which are two widely used tests in healthcare. The need for home testing has been very high during the Covid pandemic, and many people have become accustomed to taking finger pricks or other tests at home.
The digitalization of video appointments with doctors is also a very important part of the future of healthcare, but there have often been problems with not being able to carry out tests at home.
One of the most common and important blood tests is the C-Reactive Protein (CRP) test to see if a patient has a serious bacterial infection, which is only available in healthcare facilities.
Recently, CRP testing at home was approved using an AI app that can read the test strip and provide an accurate value that the doctor can access directly through a secure connection via BankID.
– We have spent a lot of time and money to realize this solution and finally we have the product CE certified to be launched throughout the EU.
Even before the approval, we have many healthcare providers and pharmacy chains that want this solution to follow up their patients.
It provides a great relief for both the caregiver and the patient to be able to handle the sampling at home,” says Denise Luxenburg Stuifbergen, CEO and co-founder of FindOut Diagnostic.
In the latest capital round, Kamjar Hajabdolahi’s BLQ Invest entered and since then the company has been supported by Add Health Media (now Curus), VNTRS and business angels including entrepreneur Alexander Stendahl.
– “I have personally been involved in the company and received so much positive feedback from investors, healthcare and patients along the way who are eager for this solution.
After this approval, I see that FindOut can become a new Swedish unicorn as the solution can now be directly used throughout the EU.
The need is very great and is growing in line with digital healthcare visits.
Both the healthcare provider and the patient want as much care as possible to be carried out at home and one piece of the puzzle is the blood tests that FindOut now has a solution for,” says Johan Bloom, CEO of the investment company Curus.
In addition to CRP, FindOut has also received CE certification for its blood test HbA1c, which measures long-term blood sugar and is an important measure of whether you start to get diabetes.
The test is important for screening and identifying patients at risk of pre-diabetes or who have already developed type 2 diabetes.  For more information: Denise Luxenburg Stuifbergen, CEO FindOut Diagnostic [email protected],+46 76 852 44 62